Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pemazyre
Pemazyre
Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time
Endpoints
Mon, 04/20/20 - 10:58 am
Incyte
Pemazyre
pemigatinib
bile duct cancer
cholangiocarcinoma
FDA